Influenza Vaccine Effectiveness in School Outbreaks During a A(H3N2) Subclade K (J.2.4.1)-Dominated Season in Beijing, China, 2025–26
Vaccination provided protection despite intense transmission settings
Mammary and respiratory infection of sheep with H5Nx clade 2.3.4.4b viruses with milk-mediated transmission to lambs
These findings establish sheep as a viable ruminant model for H5N1 and H5N5 infection and highlight previously unidentified transmission dynamics, including milk-mediated and lamb-to-ewe spread.
Human Infection with Highly Pathogenic Avian Influenza A(H5N5) Virus
Correspondence - This report shows the importance of considering avian influenza A virus infection... even when testing for influenza virus in upper-respiratory-tract specimens is negative.
Cross-reactive human antibody responses to H5N1 influenza virus neuraminidase are shaped by immune history
Early access - Individuals likely primed in childhood with H1N1 viruses possessed higher levels of antibodies that cross-react with the NA of H5N1 viruses compared to those primed with H2N2 or H3N2 viruses.
New ECDC guidance on the establishment and implementation of infection prevention and control programmes in healthcare
ESWI Activity Report for 2025
Efficacy and Safety of an mRNA Seasonal Influenza Vaccine in Adults
mRNA-1010 was superior to standard-dose licensed vaccines for prevention of RT-PCR–confirmed, protocol-defined influenza-like illness in adults 50 years of age or older. (Article for subscribers)
Progress and challenges in seasonal influenza vaccination across 54 countries and areas in the WHO European Region, 2008/09–2022/23: a repeated cross-sectional ecological study
Continued investment in national programmes is needed, especially in middle-income CA to keep increasing coverage among high-risk groups.